Your care team will answer all of your questions before beginning an intravenous infusion of a radionuclide therapy.

A member of the nuclear medicine therapy team talks with a woman before she begins intravenous peptide receptor radionuclide therapy (PRRT). This type of cancer treatment is usually done as a series of up to four infusions, usually eight weeks apart, in an outpatient setting.